Hexamer Therapeutics
Pullman, US · Founded 2019 · Delaware corporation
Hexamer Therapeutics develops a modular, room-temperature, peptide-based vaccine platform for therapeutic cancer and infectious disease vaccines, aiming to move quickly from disease target to active vaccine. It also licenses the platform to companies developing vaccines for animals such as swine, cattle, sheep, horses and companion animals.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 2 rounds · 2019–2024
▶$651.3KraisedJun 2024 · 9 investors · BiotechnologyRule 506(b)
▶$651.3KraisedJun 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ROBERT H BOGDENExecutive Officer, Director, Promoter
- KEITH MILLERDirector
- R. SCOTT BLACKLEYDirector
- COLIN COLLINSDirector
- STEPHEN CRAWFORDDirector
- Offering amount
- $6.6M
- Amount sold
- $651.3K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$469.7KraisedDec 2019 · 3 investors · BiotechnologyRule 506(b)
▶$469.7KraisedDec 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Keith David MillerExecutive Officer, Director, Promoter
- Robert Hale BogdenExecutive Officer, Director, Promoter
- Colin Conrad CollinsExecutive Officer, Director, Promoter
- Offering amount
- $1.1M
- Amount sold
- $469.7K
- Proceeds to insiders
- $1M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Hexamer Therapeutics do?
- Hexamer Therapeutics develops a modular, room-temperature, peptide-based vaccine platform for therapeutic cancer and infectious disease vaccines, aiming to move quickly from disease target to active vaccine. It also licenses the platform to companies developing vaccines for animals such as swine, cattle, sheep, horses and companion animals.
- How much funding has Hexamer Therapeutics raised?
- Hexamer Therapeutics has disclosed $1.1M raised across 2 rounds.
- Where is Hexamer Therapeutics headquartered?
- Hexamer Therapeutics is headquartered in Pullman, US.